iSSB, Institute of Systems and Synthetic Biology, CNRS UPS3509, University of Evry-Val-d'Essonne EA4527, Genopole Campus 1, Genavenir 6, 5 rue Henri Desbruères, 91030 Evry Cedex, France.
Curr Opin Biotechnol. 2012 Dec;23(6):948-56. doi: 10.1016/j.copbio.2012.03.009. Epub 2012 Apr 2.
De novo biosynthetic pathways are designed, assembled and optimized to produce high-value compounds such as drugs and chemical building blocks from renewable resources. Microorganisms are used as synthetic platforms of systems biology where biochemical pathways are engineered into the host metabolic network. Retrosynthetic biology offers a creative pathway design concept that has gained interest because of its potential to identify novel metabolic ways for therapeutic production. Retrosynthetic biology uses the backward search of retrosynthetic analysis to devise and optimize tailor-made pathways. The retrosynthetic process can be seamlessly integrated into a complete circuitry system for therapeutic applications where production, sensing and delivery act as constitutive interconnecting parts. The aim of this review is to highlight recent efforts toward synthetic design for therapeutic development.
从头设计生物合成途径,组装和优化,以可再生资源生产高价值化合物,如药物和化学砌块。微生物被用作系统生物学的合成平台,将生化途径工程化到宿主代谢网络中。回溯生物学提供了一种有创意的途径设计概念,因为它有可能为治疗性生产确定新的代谢途径,所以引起了人们的兴趣。回溯生物学使用回溯分析的反向搜索来设计和优化定制途径。回溯过程可以无缝集成到完整的电路系统中,用于治疗应用,其中生产、传感和输送作为组成性互连部分。本文综述的目的是强调最近在治疗性开发的合成设计方面的努力。